You searched for Antibody candidate - Page 66 of 69

News and Trends 14 Apr 2016

Meet the CEO who wants to transform Pretty Corals into therapies for Cancer

…antibodies – i.e. Antibody Drug Conjugate technology (ADC) – to directly administer the toxin to tumors.This would increase the efficiency of the drug, whilst reducing the number of doses needed,…

April 14, 2016 - 5 minutesmins - By Marie Godar

Best in Biotech 15 May 2018

Here Are 10 of the Hottest Biotech Hubs in Europe

…Planegg. Right there is one of Europe’s largest biotechs: MorphoSys, a billion-euro biotech that develops antibody therapies. The city is also home to Medigene, which develops T cell receptor technology…

May 15, 2018 - 10 minutesmins - By Clara Rodríguez Fernández

News and Trends 16 Feb 2016

World’s Best Journal in Medicine Publishes on Phase II Llama Antibodies

Ablynx, the llama antibody biotech in Belgium, has now proven to be on solid ground regarding their orphan drug for a rare blood disease. Now the New England Journal of…

February 16, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 1 Nov 2022

Human Immunology Biosciences launches with $120M

…enhancements that come with our approach.” Clinical-stage assets HI-Bio’s clinical-stage assets include felzartamab, an anti-CD38 antibody, and HIB210, an anti-C5aR1 antibody. Felzartamab targets a protein expressed on the surface of…

November 1, 2022 - 4 minutesmins - By Jim Cornall

Best in Biotech 28 Feb 2023

10 biotech companies making a difference in rare diseases

…Founded: 2019 Alchemab Therapeutics is a biotechnology company working on harnessing the power of the immune system to create the next generation of antibody therapeutics for hard-to-treat diseases that do…

February 28, 2023 - 11 minutesmins - By Willow Shah-Neville

In Depth 6 Mar 2023

The biggest private biotech investments in February 2023

…will be used to finance an ongoing phase 1/2 trial of a bispecific antibody treatment for the rare bleeding condition Glanzmann thrombasthenia in addition to the launch of a phase…

March 6, 2023 - 4 minutesmins - By Jonathan Smith

News and Trends 16 Nov 2020

Innate Immunity in Cancer Gains Recognition with Affimed’s €1.8B Deal

…deal’s terms, Affimed will receive €51M upfront to license to Roivant a preclinical-stage antibody drug for several undisclosed types of cancer. Roivant will handle the program once Affimed completes preclinical…

November 16, 2020 - 3 minutesmins - By Jonathan Smith

ethris mrna therapy respiratory infection

News and Trends 1 Feb 2022

Ethris Raises €23M to Make Inhaled Respiratory Therapies from mRNA

…Series B round to fund the development of its lead candidate mRNA therapies — one for respiratory viral infections and the other for the genetic lung condition primary ciliary dyskinesia….

February 1, 2022 - 3 minutesmins - By Jonathan Smith

In Depth 26 May 2023

Could new Lyme disease tests help to prevent chronic infection?

…order to create a better Lyme disease test. Dr Abdo Alnabulsi, chief executive officer (CEO) of EpitogenX, stated: “We are working on a serology based antibody test for the detection…

May 26, 2023 - 10 minutesmins - By Willow Shah-Neville

News and Trends 17 Mar 2016

A Relief for Migraines at last? The Biotech race for the Ultimate Cure

…are in the race for approval of the first migraine antibody drug. These include Teva (Israel) with the drug called TEV-48125 as well the US based Amgen, Eli Lilly and…

March 17, 2016 - 4 minutesmins - By Ekaterina Perets

News and Trends 21 Feb 2018

FDA Approves AstraZeneca’s Lung Cancer Treatment after Rejecting Merck and Pfizer’s

…type of monoclonal antibody known as a checkpoint inhibitor that targets the immune regulatory molecule PD-L1. The FDA approval for Imfinzi is the first authorization of a treatment for lung…

February 21, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 12 Jun 2017

BioNTech Publishes First Data on mRNA-Encoded Cancer Antibodies

BioNTech has reported a new technology that could overcome some of the most challenging issues of antibody production by encoding them into mRNA drugs. BioNTech, one of the most advanced…

June 12, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Meet the CEO who wants to transform Pretty Corals into therapies for Cancer

Here Are 10 of the Hottest Biotech Hubs in Europe

World’s Best Journal in Medicine Publishes on Phase II Llama Antibodies

Human Immunology Biosciences launches with $120M

10 biotech companies making a difference in rare diseases

The biggest private biotech investments in February 2023

Innate Immunity in Cancer Gains Recognition with Affimed’s €1.8B Deal

Ethris Raises €23M to Make Inhaled Respiratory Therapies from mRNA

Could new Lyme disease tests help to prevent chronic infection?

A Relief for Migraines at last? The Biotech race for the Ultimate Cure

FDA Approves AstraZeneca’s Lung Cancer Treatment after Rejecting Merck and Pfizer’s

BioNTech Publishes First Data on mRNA-Encoded Cancer Antibodies

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!